» Authors » Alex Olvera

Alex Olvera

Explore the profile of Alex Olvera including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 684
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bailon L, Puertas M, Garcia-Guerrero M, Moraes-Cardoso I, Aparicio E, Alarcon-Soto Y, et al.
J Infect Dis . 2024 Oct; PMID: 39465671
Objective: To compare the effects of first-line antiretroviral treatment (ART) with dolutegravir plus lamivudine (DTG+3TC) versus DTG plus emtricitabine/tenofovir alafenamide (FTC/TAF) on the evolution of the HIV-1 reservoir and immune...
2.
Moraes-Cardoso I, Benet S, Carabelli J, Perez-Zsolt D, Mendoza A, Rivero A, et al.
Lancet Microbe . 2024 Jun; 5(8):100859. PMID: 38857615
Background: Since the emergence of the global mpox outbreak in May, 2022, more than 90 000 cases have been diagnosed across 110 countries, disproportionately affecting people with HIV. The durability...
3.
Olvera A, Romero-Martin L, Oriol-Tordera B, Rosas-Umbert M, Escriba T, Mothe B, et al.
Vaccines (Basel) . 2024 Mar; 12(3). PMID: 38543913
The efficacy of anti-viral T-cell vaccines may greatly depend on their ability to generate high-magnitude responses targeting a broad range of different epitopes. Recently, we created the HIV T-cell immunogen...
4.
Elizalde-Torrent A, Borgognone A, Casadella M, Romero-Martin L, Escriba T, Parera M, et al.
Vaccines (Basel) . 2023 Nov; 11(11). PMID: 38005995
Despite the important role of gut microbiota in the maturation of the immune system, little is known about its impact on the development of T-cell responses to vaccination. Here, we...
5.
Borgognone A, Elizalde-Torrent A, Casadella M, Romero L, Escriba T, Parera M, et al.
NPJ Biofilms Microbiomes . 2022 Dec; 8(1):104. PMID: 36585401
The gut microbiota is emerging as a crucial factor modulating vaccine responses; however, few studies have investigated if vaccines, in turn, can alter the microbiota and to what extent such...
6.
Romero-Martin L, Duran-Castells C, Olivella M, Rosas-Umbert M, Ruiz-Riol M, Sanchez J, et al.
Front Immunol . 2022 Dec; 13:1027855. PMID: 36466823
The contribution of the HLA-E/NKG2X axis in NK-mediated control of HIV infection remains unclear. We have studied the relationship between HLA-E expression and phenotypical as well as functional characteristics of...
7.
Romero-Martin L, Tarres-Freixas F, Pedreno-Lopez N, Rodriguez de la Concepcion M, Cunyat F, Hartigan-OConnor D, et al.
Front Immunol . 2022 Jul; 13:928039. PMID: 35784304
T cell responses are considered critical for the control of HIV, but the contribution of different T cell subsets to this control remains unclear. Using a boosted flow cytometric approach...
8.
Aguado-Garcia D, Olvera A, Brander C, Sanchez-Merino V, Yuste E
Vaccines (Basel) . 2022 Apr; 10(4). PMID: 35455233
The long-term storage stability of vaccines has a major impact on the roll-out and success of global immunization programs. For the Human Immunodeficiency Virus type 1 (HIV-1) virus-like particle (VLP)...
9.
Beltran-Pavez C, Bontjer I, Gonzalez N, Pernas M, Merino-Mansilla A, Olvera A, et al.
J Virol . 2021 Oct; 96(1):e0134321. PMID: 34668778
Longitudinal studies in HIV-1-infected individuals have indicated that 2 to 3 years of infection are required to develop broadly neutralizing antibodies. However, we have previously identified individuals with broadly neutralizing...
10.
Olvera A, Cedeno S, Llano A, Mothe B, Sanchez J, Arsequell G, et al.
Front Immunol . 2021 Feb; 11:573928. PMID: 33552045
It is largely unknown how post-translational protein modifications, including glycosylation, impacts recognition of self and non-self T cell epitopes presented by HLA molecules. Data in the literature indicate that -...